Cai said the performance of Livzon Group is currently weak, can the overweight Chinese medicine sector break the situation?

Reporter | Fan Jiazhi

The latest annual report shows that Livzon Group (000513.

In 2020, Livzon Group achieved operating income of 10.

Livzon Group stated in its annual report that the overall rapid growth in performance was due to the rapid increase in sales of its main product, ilaprazole sodium for injection

Data source: Announcement, Interface News Research Department

The peaks of Livzon Group’s performance net profit and revenue appeared in the second and third quarters of 2020, respectively

Perhaps it is that antiviral particles and other traditional Chinese medicine preparations are once again favored by the market, and Livzon Group has decided to continue to increase its size in the traditional Chinese medicine sector

This Tongrentang is not the other Tongrentang

At present, Tianjin Tongrentang is sprinting for IPO

Livzon Group stated in the announcement that the company can cooperate with Tianjin Tongrentang at the level of traditional Chinese medicine business, and can also realize corresponding investment income through its cash dividends or initial public offerings

If this transaction takes place, Livzon Group will add another company to be listed

In August 2020, Livzon Group announced the separation of the in vitro diagnostics (hereinafter referred to as IVD) segment-Zhuhai Livzon Reagent Co.

After the outbreak of the new crown epidemic, the Wuhan Institute of Virology, Chinese Academy of Sciences quickly launched research work related to the new crown virus and chose to cooperate with Livzon Group for development

An important reason for splitting Livzon reagent is valuation

Livzonumab, the monoclonal antibody sector that started the spin-off plan earlier, has not followed suit

This may be the reason why Livzon Group has turned its attention to Livzon reagents and even the Chinese medicine sector

Traditional Chinese medicine preparations and new coronavirus antibody detection kits conceal the weakness of Livzon Group’s main business growth

As of the close at noon on March 23, Livzon Group closed at 40.